imaging biomarkers of breast cancer risk and response to treatment
risk prediction
breast cancer screening
pharmacogenetics
maternal exposures and neurodevelopment
autism spectrum disorder
ADHD
Education & Training History
PhD Epidemiology – New York University
MSc Nutritional Sciences – University of Toronto
BSc Biological Sciences – University of Guelph
Professional Summary & Appointments
2014 Assistant Professor of Epidemiology – Dalla Lana School of Public Health, University of Toronto
2014 Assistant Attending Level 1 – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY NY USA
2012-2014 Instructor – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY NY USA
2009-2012 Research Scholar – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY NY USA
Primary teaching responsibilities
Categorical Data Analysis for Epidemiologists (CHL5407)
Epidemiology Methods 1 (CHL5401)
Supervision of graduate students
Ongoing research projects
Prediction of risk of cardiovascular disease in women diagnosed with early stage breast cancer. (CIHR funded: 2017-2019)
Developing tools that predict use of breast cancer screening and stage at breast cancer diagnosis. (CIHR funded: 2017-2019)
Province of Ontario neurodevelopmental Network (POND). (Ontario Brain Institute funded: 2018-2023)
Personalized risk assessment for prevention and early detection of breast cancer: Integration and Implementation (PERSPECTIVE I&I) (Genome Canada, Genome Quebec, Ontario Research Fund funded: 2018-2022)
MRI parenchymal enhancement and risk of breast cancer: A population-based study of women screened in the Ontario Breast Screening Program. (CIHR funded: 2017-2021)
Linkage of whole genome sequencing and administrative health data for the study of autism spectrum disorder (ASD). (McLaughlin Centre funded: 2017-2018)
Molecular pathoepidemiology of contralateral breast cancer. (US NCI funded: 2017-2021)
MRI background parenchymal enhancement as a risk factor for breast cancer. (US NCI funded: 2014-2017)
CYP2D6 phenotype, tamoxifen treatment and risk of contralateral breast cancer in the WECARE Study Population (Chanel Endowment to Fund Survivorship Research funded: 2014-2016)
Histopathologic Characteristics of MRI Background Parenchymal Enhancement as a Biomarker of Breast Cancer Risk (Survivorship Outcomes And Risk (SOAR) Developmental Funds Award (MSK) funded: 2015)
Tumor effects on the measurement of enhancement on breast MRI: Implications for study design. (MSK/Goldstein Family Foundation funded: 2014)